Biotech

All Articles

Eli Lilly leaps deeper right into AI along with $409M Hereditary Leap package

.Eli Lilly has actually risen into an AI-enabled medicine invention package, partnering with RNA pro...

After FDA denial and also cutbacks, Lykos CEO is actually leaving behind

.Lykos chief executive officer and also creator Amy Emerson is actually walking out, with main funct...

Novartis ignites brand-new stage of Voyager pact with $15M capsid offer

.Novartis levels a new frontier in its partnership with Voyager Therapies, paying $15 million to tak...

Lilly articles a lot more beneficial records on its regular the hormone insulin possibility

.On the heels of an FDA being rejected for its own primary rivalrous Novo Nordisk, Eli Lilly is actu...

IN 8bio halts stage 2 test, lays off fifty percent of workforce

.Only a handful of months after application the 1st individual in a stage 2 trial for recently detec...

Lilly, Haya ink $1B biobuck being overweight treaty to look dark genome

.Eli Lilly's look for obesity intendeds has actually led it to the black genome. The Big Pharma has ...

ArsenalBio increases $325M, rotates off of former lead possession

.Arsenal Biosciences is actually carrying on up. The cell treatment business has actually added on $...

Lilly- supported fat loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually sub...

Aelis' marijuana use drug flunks period 2b, driving Indivior to reassess $100M option

.Aelis Farma's hopes of securing a fast, beneficial decision on a $one hundred million option repaym...

ProKidney stops phase 3 test not required for cell treatment authorization

.ProKidney has quit one of a pair of phase 3 trials for its own cell therapy for renal illness after...